Professor James Chalmers is joined by Professors Jodie Simpson and Wisia Wedzicha to discuss the role of prophylactic antibiotic treatment in the prevention of exacerbations. They review current evidence from randomised trials, demonstrating the effect of long-term antibiotic treatment on exacerbation rates and symptoms in asthma, COPD, bronchiectasis and other diseases... Listen on Soundcloud Listen on Spotify

To take part in this event, you must register in advance. REGISTER NOW Registered participants - access the live stream for ERS Satellites 2024 JOIN LIVE 5 March, 2024 | Online Join us on 5 March for the seventh edition of the award-winning ERS Satellites. Registration is open now. 'The go-to update for busy clinicians' "Over the past six years, the ERS Satellites event has become the 'go to' update for busy clinicians. Focused on four core respiratory conditions, the globally recognised speakers will address a spectrum of topics from basic and translational science to implementation in routine clinical practice - and this year we have a sub-theme of digital care. ERS Satellites is delivered using live-streaming technology, so the sessions are accessible and it is easy to participate with questions and discussion as a virtual delegate." - Prof. Hilary Pinnock, event co-chair About the programme The 2024 edition will be chaired by Prof. Dr Hilary Pinnock and Prof. Nicolas Roche and will feature a full-day programme focusing on: COPD Asthma Bronchiectasis Infections. Each session will cover: Disease mechanisms & understanding State of the art (recent literature) & treatment approaches Application of current knowledge & clinical perspective with cases Revisit content from 2023 Session replays from ERS Satellites 2023 are available exclusively on the ERS Respiratory Channel. Comments from past delegates "Seriously, this is the future of education." "Excellent interaction! The event truly exceeded my expectations, thank you!" "Great combination of venue and online hub webcast." "It was brilliant, should happen more often." "It was very stimulating to hear and watch the talks from all over Europe, really felt like the speakers were in front of you all the time." "Wonderful event. Delighted to be part of history!" "All the talks were excellent. The Q&A was outstanding." CME accreditation This event has received official CME accreditation from the European Board for Accreditation in Pneumology (EBAP). The ERS Satellites programme is accredited and offers participants seven CME credits for the live event only. Please note that credits cannot be accrued for watching session replays. Note: The ERS Satellites programme has been created by the European Respiratory Society and there has been no external influence on the content or choice of speakers. Featuring chairpersons from our supporting partner societies With the financial support of

14 May, 2024 | Online17:00-18:00 CESTChairs: Dr Stefan Unger (Edinburgh, United Kingdom), Dr Nadine Freitag (Krefeld, Germany)Speakers: Prof. Dr Timothy Hinks (Oxford, United Kingdom), Prof. Andrew Bush (London, United Kingdom) Overview Azithromycin is frequently used in paediatric and adult respiratory medicine. Educating healthcare professions and researchers about the evidence for the antibacterial, anti-inflammatory and antiviral properties of azithromycin to provide a better understanding of the bases for use in a variety of acute and chronic respiratory diseases, both in adult and paediatric medicine. It helps the audience to apply the knowledge to every day practice and highlight areas where further research is required. Educational aims The webinar will provide details for the use of azithromycin in respiratory diseases including: Asthma Viral infections Chronic suppurative lung diseases including bronchiectasis and PCD The webinar will help participants to develop a better understanding of the drug actions and impact in clinical practice. Topics Azithromycin in asthma and viral infections Antiviral and anti-inflammatory properties of azithromycin in cystic fibrosis Azithromycin in Chronic Suppurative Lung Disease Target audience Paediatric respiratory consultants Adult respiratory consultants Paediatric and adult respiratory medicine trainees Paediatric and adult respiratory nurses and physiotherapists Learning outcomes Following this webinar, participants will be able to: Have an understanding of the antibacterial, anti-inflammatory and antiviral properties of azithromycin Understand the role of azithromycin in some of the major respiratory diseases Recognise limitation of our knowledge on the mechanisms of the drug Recognise potential side effects and concerns regarding antimicrobial resistance Have an understanding of some of the guidelines regarding azithromycin use in practice

To take part in this event, you must register in advance. REGISTER NOW Access the live stream from 18 June, 2024. WATCH LIVE   18-20 June, 2024 Overview The Academy of paediatric respiratory medicine is intended to provide a comprehensive overview of each of the major fields of paediatric respiratory medicine, based on the HERMES syllabus. This academy is aimed at all paediatric respiratory professionals wishing to update their knowledge, particularly those preparing for the European examination in paediatric respiratory medicine.     The course programme is designed to challenge participants and provide a learning framework. It includes interactive case-based sessions and discussions, lectures with key updates in the field, a Q&A session for participants, and a broad selection of pre-recorded lectures.     Participants will have the opportunity to review online learning modules at their own pace before attending part one, online from 18-20 June, 2024. Part two will take place during the ERS Congress 2024 in Vienna, Austria and will consist of case-based sessions where medical practitioners will have the opportunity to align their current procedures with the latest clinical best practice. The aim of these sessions is to disseminate established practices with dedicated time for one-to-one interaction between participants and faculty.     Participants may register for Part one (Online) exclusively or Part one (Online) + Part two (Vienna). Academy modules Airway endoscopy Acute respiratory infections Congenital malformations Lung function testing Bronchial asthma and wheezing disorders Imaging and sleep medicine Cystic fibrosis, protracted bacterial bronchitis and non-CF bronchiectasis Tuberculosis Rare diseases Course format Pre-recorded online modules Part one: Lectures with key updates, interactive polls and Q&A discussion time Case-based sessions Please note that all timings are in Central European Summer Time (CEST). Recordings of each session will be made available to registered participants within two weeks after the event, with the exception of the on-site sessions in Vienna, Austria.Replays will remain accessible until December 2024 on the ERS Respiratory Channel. Learning outcomes Following this course, participants will gain detailed knowledge of: The major fields of paediatric respiratory medicine The HERMES syllabus modules Best practice in how to prepare for the European examination in paediatric respiratory medicine Accreditation Part one of the Academy event has been accredited with 17.5 CME credits by the European Board for Accreditation in Pneumology (EBAP).

8 October, 2024 | Online18:00-19:00 CESTChairs: Prof. Dr Renato Cutrera (Rome, Italy), Dr Federica Porcaro (Rome, Italy)Speakers: Prof. Anastassios Koumbourlis (Washington, United States), Dr Thomas Kovesi (Ottawa, Canada), Mrs. Danielle Carrier (Gatineau, Québec, Canada), Ms. Emma Squires (Gatineau, Québec, Canada)Fees: Free for ERS members / €10 for non-membersFind out more about becoming a member Overview Tracheoesophageal fistula (TEF) is a rare congenital anomaly with long-term respiratory and gastrointestinal sequelae. The International Esophageal Atresia Association has now published care recommendations on the management of patients with TEF, and consensus guidelines on the transitioning of youth with TEF to medical care. This session will review these recommendations. Educational aims Recognise the long-term respiratory complications of tracheoesophageal fistula (TEF)Describe the evaluation of TEF patients who have respiratory symptoms or deteriorating pulmonary functionIdentify appropriate respiratory monitoring of children and adults with a history of TEFDescribe the components of a successful transition programme for youth with TEF Topics This webinar will focus on congenital anomalies, tracheomalacia, tracheoesophageal fistula, aspiration, gastroesophageal reflux, bronchiectasis, asthma, and pulmonary function. The presentations are as follows. Patient's and parent's perspective - Danielle Carrier, Emma SquiresEvaluation of the patient with tracheoesophageal fistula with persistent symptoms or worsening respiratory status - Anastassios KoumbourlisNew transition guidelines for TEF patients - Thomas Kovesi Target audience Paediatric respirologistsAdult respirologistsNurse practitionersNurse coordinators Learning outcomes Following this webinar, participants will recognise how to: Monitor TEF patientsAppropriately investigate a patient with TEF with recurrent infections, chronic cough or wheeze, or worsening lung functionStep toward effective transitioning to adult medical care CME credit An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only. What is a webinar? A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls. All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone. Login guidelines More information will be communicated in due course. Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.Check Central European Time.To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.

To take part in this event, you must register in advance. REGISTER NOW Access the live stream from 17 June, 2025. WATCH LIVE 17-19 June, 2025 Overview The Academy of paediatric respiratory medicine is intended to provide a comprehensive overview of each of the major fields of paediatric respiratory medicine, based on the HERMES syllabus. This academy is aimed at all paediatric respiratory professionals wishing to update their knowledge, particularly those preparing for the European examination in paediatric respiratory medicine.The course programme is designed to challenge participants and provide a learning framework. It includes interactive case-based sessions and discussions, lectures with key updates in the field, a Q&A session for participants, and a broad selection of pre-recorded lectures.Participants will have the opportunity to review online learning modules at their own pace before attending part one, online from 17-19 June, 2025. Part two will take place during the ERS Congress 2025 in Amsterdam, Netherlands and will consist of case-based sessions where medical practitioners will have the opportunity to align their current procedures with the latest clinical best practice. The aim of these sessions is to disseminate established practices with dedicated time for one-to-one interaction between participants and faculty.Participants may register for part one (online) exclusively or part one (online) and part two (Amsterdam, Netherlands).Registered participants can also benefit from a discount when registering for the ERS HERMES self-assessment course in paediatric respiratory medicine taking place on Friday, 20 June 2025. This will be an excellent opportunity to test what you have learnt at the academy and prepare for the European examination in paediatric respiratory medicine. The self-assessment course consists of a one-hour mock examination (30 case-based multiple-choice questions selected from the pool of the HERMES examination in respiratory medicine) followed by a two-hour discussion with ERS experts. Academy modules Airway endoscopy Acute respiratory infections Congenital malformations Lung function testing Bronchial asthma and wheezing disorders Imaging and sleep medicine Cystic fibrosis, protracted bacterial bronchitis and non-CF bronchiectasis Tuberculosis Rare diseases Course format Pre-recorded online modules Part one: Lectures with key updates, interactive polls and Q&A discussion time Case-based sessions Please note that all timings are in Central European Summer Time (CEST). Recordings of each session will be made available to registered participants within two weeks after the event, with the exception of the on-site sessions in Amsterdam, Netherlands.Replays will remain accessible until December 2025 on the ERS Respiratory Channel. Learning outcomes Following this course, participants will gain detailed knowledge of: The major fields of paediatric respiratory medicine The HERMES syllabus modules Best practice in how to prepare for the European examination in paediatric respiratory medicine Accreditation An application will be submitted to the European Board for Accreditation in Pneumology (EBAP) for CME accreditation of this event. Part one:The number of credits that you will receive will correspond to the time you spend viewing the sessions livePlease note that you need to join the live stream with the name that corresponds to your myERS profile to ensure that you receive the CME creditsParticipants will not accrue credits for watching video recordings made available after the course has taken place 

Overview This ERS Vision Live panel discussion is entitled 'Sarcoidosis - bringing innovation into clinical practice'.   The expert panellists will discuss key areas, including: • Innovation in diagnostics.• New insights in phenotyping/endotyping sarcoidosis patients.• New perspectives in management, treatment and clinical trials. Co-Chairs   Prof. Dr Francesco Bonella (co-chair) • Francesco is Professor of Medicine and Head of the Center for Interstitial and Rare Lung Disease at the Ruhrlandklinik University Hospital in Essen, Germany. • His research interests include sarcoidosis, IPF, autoimmune ILD, and pulmonary alveolar proteinosis with a special focus on biomarkers, genetics, and AI applications in radiology. • Francesco is actively involved with the European Respiratory Society (ERS) since 2014, has founded EuPAPNet, the European Network for pulmonary alveolar proteinosis, and is Coordinator of the Sarcoidosis Core Network within ERN-LUNG. • He is member of the Editorial Board of the European Respiratory Journal, Chest and Associate Editor of Respirology.     Prof. Adriane Vorselaars (co-chair) • Adriane is a pulmonologist and sarcoidosis specialist based in University Medical Center Utrecht and the Interstitial Lung diseases Center of Excellence Nieuwegein, Netherlands.• She is active in the research field of sarcoidosis, pulmonary fibrosis, CTD-ILD with a special interest in biomarkers, treatment and eHealth/telemonitoring. • She is actively involved in the ERS as organiser of the ERS school of sarcoidosis, which is held yearly both live and virtually. • As of 2005, she is a member of the executive committee of the World Association of Sarcoidosis and other Granulomatous disorders (WASOG).   Speakers   Dr Karol Baczek • Karol is a physician specializing in interstitial lung disease (ILD) with special focus on sarcoidosis and a PhD candidate at the Medical University of Lodz in Poland.• Karol was a visiting scientist at the Ruhrlandklinik - Universitätsmedizin Essen.• As an early career member of the ERS ILD Assembly, he is involved in collaborative research and professional development within the ERS.• His contributions to pulmonary medicine have been recognised with multiple travel grants and the Medal of the 90th Anniversary of the Polish Respiratory Society.     Dr Natalia Rivera • Natalia is an Assistant Professor at the Division of Inflammation and Respiratory Medicine, Department of Medicine Solna at Karolinska Institutet, Stockholm, Sweden.• She is a Team Leader at the Center for Molecular Medicine, leading genomic research on sarcoidosis.• Natalia is the former chair of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) 2023 Congress and serves on the Executive Board of WASOG.• She is an active member of the ERS assembly/group 12.03 "Sarcoidosis and other granulomatous ILD/DPLD," often serving as session chair and reviewer of congress abstracts.     Prof. Elena Bargagli • Elena is Full Professor and Director of the Respiratory Diseases Unit at Hospital University of Siena, Italy.• She is Coordinator of the Tuscany Regional Referral Centre for Lung Transplantation and Rare Lung Diseases.• Her clinical interests include connective tissue disease-associated interstitial lung diseases (ILD), idiopathic interstitial pneumonias (IIPs), sarcoidosis and hypersensitivity pneumonitis (HP), Pulmonary Langerhans'cell histiocytosis (PLCH) and lymphangioleyomyomatosis (LAM).• She is past Group Chair for the ERS Assembly 12.02 Interstitial Lung Diseases and has published several manuscripts about biomarkers in different diffuse lung diseases.

The latest episode of Curbside Consult focuses on bronchoscopy in difficult situations. Co-hosts Dr Emer Kelly (St Vincent's University Hospital, Dublin, Ireland) and Prof. Sean Gaine (The Mater Hospital, Dublin, Ireland) are joined by Associate Prof. Konstantina Kontogianni (University of Heidelberg, Germany). Emer, Sean and Konstantina discuss the case of a 32-year-old female non-smoker with hemoptysis. The patient has undertaken a chest x-ray at a rapid-access clinic. The chest x-ray shows a small amount of atelectasis and the patient is required to have a bronchoscopy. During bronchoscopy, a polypoid lesion is found that looks vascular. What should be done?

Overview This instalment of ERV Vision Live saw the expert panel, co-chaired by Prof. Winfried Randerath and Prof. Sophia Schiza, discuss adaptive servoventilation (ASV) for central sleep apnoea (CSA). The expert panellists discussed key areas, including: • CSA, from pathophysiology to phenotypes to diagnostic procedures.• ASV treatment for CSA-Cheyne-Stokes breathing, current knowledge and future perspectives.• Therapeutic options beyond ASV for CSA.     Co-Chairs Prof. Winfried Randerath • Winfried holds the position of Medical Director at the Bethanien Hospital, Solingen, Germany, Clinic for Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care as well as the position of Director of the Institute of Pneumology at the University of Cologne. • His main research activities are differentiation of obstructive and central sleep apnoea, interaction of sleep apnoea and the heart, pulmonary intensive care, and chronic respiratory failure.• Winfried is a Fellow of the American Thoracic Society, the American Association of Sleep Medicine, the American College of Chest Physicians, and was awarded the Teaching Award of the European Respiratory Society and the Meier-Ewert-Price of the German Dental Sleep Medicine Society.• Within ERS he has held many roles, including Head of Assembly 4 (Sleep-disordered breathing) from 2021-2023, and he is currently Guidelines Director for the period 2024-2027. Prof. Sophia Schiza • Sophia is Professor of Respiratory and Sleep Medicine and Head of Respiratory Department and Sleep Disorders Center, School of Medicine, University of Crete.• Since 2023, she has been Head of ERS Assembly 4 (Sleep-disordered breathing).• As well as receiving the ERS Teaching Award in 2019 and 2024, she became a Fellow of ERS in 2022.• She is a member of numerous ERS task forces and guidelines and joint ERS and European Sleep Research Society (ESRS) task forces, including her role as co-chair for the ERS Statement for the use of adaptive servo-ventilation (ASV) in central sleep apnea (CSA).• She chairs the committee for the ERS Respiratory Sleep Training Programme and is a member of the organising committee of the biannual ERS/ESRS Sleep and Breathing Congress.• She serves as Associate Editor for Sleep Medicine. Speakers Prof. Johan Verbraecken • Johan is Medical Coordinator of the Multidisciplinary Sleep Disorders Centre of the Antwerp University Hospital in Belgium.• Since 2001, he has been a staff member at the Antwerp University Hospital, Belgium, and is currently Associate Professor and Training Director for Pulmonology at the University of Antwerp.• At the European level, he was Secretary and Chair of the ERS Sleep and Control of Breathing Group, ERS E-Learning Director, Chair of the ERS Accreditation Review Committee for respiratory training centres, member of the Executive Committee of the Assembly of National Sleep Societies, and co-opted ESRS Board member.• Johan is a former President of the Belgian Association for Sleep Research and Sleep Medicine. Prof. Esther Schwarz • Esther is a respiratory and sleep physician.• She is Vice-Clinical Director of the Department of Pulmonology and Head of the Sleep Disorders Centre and Ventilation Unit at the University Hospital Zurich in Switzerland, and Professor of Respiratory and Sleep Medicine at the University of Zurich.• The work of her research group focuses on cardiovascular consequences of obstructive sleep apnoea, pathophysiology of sleep-disordered breathing and chronic respiratory failure, and on treatment outcomes in obstructive sleep apnea and on home mechanical ventilation. • She is Secretary of Assembly 4 (sleep-disordered breathing) of the ERS and Co-President of the working group for ventilation and oxygen of the Swiss Society of Pulmonology.   Dr Rami Khayat • Rami is currently the Division Chief of Pulmonary, Allergy and Critical Care Medicine and Director of Sleep Medicine at Penn State University in the United States of America.• His research interests are in CSA treatment, especially in patients with heart failure.• He has published research on therapies, including ASV and phrenic nerve stimulation.